Prostatic Neoplasms, Castration-Resistant trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All Prostatic Neoplasms, Castration-Resistant trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
  NCT07225946 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Lisle
• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
  NCT04104776 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago, Maywood